Furthermore, increased FBN1 expression in cisplatin-resistant ovarian cancer models indicates that the Fibrillin-1/VEGFR2/STAT2 axis plays a regulatory role in glycolysis and angiogenesis, thereby contributing to cisplatin resistance (86). Here, FBN1 is linked to ovarian carcinoma.